Julian Bowen Consort Dining Table, Honey, Height: 77, Width: 92, Depth: 92cm

Product Information

Knottnerus JA, Tugwell P. The standards for reporting of diagnostic accuracy. J Clin Epidemiol 2003;56:1118e27 Shamseer L, Hopewell S, Altman DG, Moher D, Schulz KF. Update on the endorsement of CONSORT by high impact factor journals: a survey of journal ‘instructions to authors’ in 2014. Trials. 2016;17(1):301. Hopewell S, Clarke M, Moher D, et al. CONSORT for reporting randomised trials in journal and conference abstracts. Lancet. 2008;371:281–3. The main CONSORT Statement is based on the "standard" two-group parallel design. Extensions of the CONSORT Statement have been developed to give additional guidance for randomized trials with specific designs (e.g., cluster randomized trials, [3] noninferiority and equivalence trials, [4] pragmatic trials, [5]), data (e.g., harms, [6] abstracts [7]), and various types of intervention (e.g., herbals, [8] non-pharmacologic treatments, [9] acupuncture [10]). A number of guidelines have been designed to complement CONSORT, including TIDieR (encouraging adequate descriptions of interventions) [11] and TIDieR-Placebo (encouraging adequate descriptions of placebo or sham controls). [12] This list is by no means exhaustive, and work is ongoing.

Julian Bowen Consort Dining Table, Honey, Height: 77, Width Julian Bowen Consort Dining Table, Honey, Height: 77, Width

West R. Providing full manuals and intervention descriptions: addiction policy. Addiction. 2008;103:1411.Taichman DB, Sahni P, Pinborg A, et al. Data sharing statements for clinical trials: a requirement of the International Committee of Medical Journal Editors. JAMA. 2017;317(24):2491–2. Simmons JP, Nelson LD, Simonsohn U. False-positive psychology: undisclosed flexibility in data collection and analysis allows presenting anything as significant. Psychol Sci. 2011;22(11):1359–66. In addition to the eligibility criteria that apply to individuals, social and psychological intervention trials often have eligibility criteria for the settings where participants will be recruited and interventions delivered, as well as intervention providers [ 44]. Authors should describe these criteria to help readers compare the trial context with other contexts in which interventions might be used [ 48, 66, 67]. Item 4b: settings and locations of intervention delivery and where the data were collected

The CONSORT statement - PMC - National Center for The CONSORT statement - PMC - National Center for

Hopewell S, Altman DG, Moher D, Schulz KF. Endorsement of the CONSORT statement by high impact factor medical journals: a survey of journal editors and journal ‘Instructions to Authors’. Trials. 2008;9:20. Fletcher A, Jamal F, Moore G, Evans RE, Murphy S, Bonell C. Realist complex intervention science: applying realist principles across all phases of the Medical Research Council framework for developing and evaluating complex interventions. Evaluation. 2016;22(3):286–303. CONSORT 2010 has been translated into the following languages: Chinese; French; German; Greek; Italian; Japanese; Persian; Polish; Portuguese; Russian; Spanish; Turkish. The dates of a trial and its activities provide readers some information about the historical context of the trial [ 48]. The SPIRIT 2013 Statement includes a table that authors can use to provide a complete schedule of trial activities, including recruitment practices, pre-randomisation assessments, periods of intervention delivery, a schedule of post-randomisation assessments, and when the trial was stopped [ 55]. In the description, authors should define baseline assessment and follow-up times relative to randomisation. For example, by itself, ‘4-week follow-up’ is unclear and could mean different things if meant after randomisation or after the end of an intervention. Item 14b: why the trial ended or was stopped Concurrently, and independently, another group of experts, the Asilomar Working Group on Recommendations for Reporting of Clinical Trials in the Biomedical Literature, convened in California, USA, and were working on a similar mandate. This group also published recommendations for authors reporting randomized trials. [14]

Particularly because masking providers and participants is impossible in many social and psychological intervention trials, authors should describe any differences between interventions delivered to each group that could lead to differences in the performance and expectations of providers and participants. Important details include differences in intervention components and acceptability, co-interventions (or adjunctive interventions) that might be available to some groups and not others, and contextual differences between groups (e.g. differences in place of delivery). Methods: analytical methods Item 12a: statistical methods used to compare group outcomes Davidoff F, Dixon-Woods M, Leviton L, Michie S. Demystifying theory and its use in improvement. BMJ Qual Saf. 2015;24(3):228–38. Information about trial funding and support is important in helping readers to identify potential conflicts of interest. Authors should identify and describe all sources of monetary or material support for the trial, including salary support for trial investigators and resources provided or donated for any phase of the trial (e.g. space, intervention materials, assessment tools). Authors should report the name of the persons or entities supported, the name of the funder, and the award number. They should also specifically state if these sources had any role in the design, conduct, analysis, and reporting of the trial, and the nature of any involvement or influence. If funders had no involvement or influence, authors should specifically report this. CONSORT-SPI item 25b: declaration of any other potential interests

Glass Console Tables UK for Sale | Furniture in Fashion Glass Console Tables UK for Sale | Furniture in Fashion

Shamseer L, Sampson M, Bukutu C, et al. CONSORT extension for N-of-1 trials (CENT) guidelines. BMC Complement Altern Med. 2012;12(Suppl 1):P140.MRC-NIHR Trials Methodology Research Partnership, Department of Health Data Science, University of Liverpool, Liverpool, England.